SA
Create Free Alerts
LifeVantage CorporationLFVNNASDAQ
Loading
OverviewIntelligenceCharts
R&D Expense Growth Under PressureDecelerating
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Latest
0.00%
↓ 100% vs avg
Percentile
P18
Within normal range
Average
12.04%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 2024-100.00%
Q1 2024100.00%
Q4 2023-50.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 20220.00%
Q2 20220.00%
Q1 20220.00%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 2019-100.00%
Q3 2019100.00%
Q2 20190.00%
Q1 2019-80.00%
Q4 201825.00%
Q3 20180.00%
Q2 201833.33%
Q1 20180.00%
Q4 20170.00%
Q3 20170.00%
Q2 201750.00%
Q1 2017-33.33%
Q4 20160.00%
Q3 2016-80.00%
Q2 2016650.00%
Q1 2016-33.33%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance